Lack of Long-Term Neurologic Efficacy of Zileuton in Sjögren-Larsson's Syndrome

Neuropediatrics. 2017 Jun;48(3):205-206. doi: 10.1055/s-0037-1601856. Epub 2017 Apr 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Humans
  • Hydroxyurea / administration & dosage
  • Hydroxyurea / adverse effects
  • Hydroxyurea / analogs & derivatives*
  • Hydroxyurea / pharmacology
  • Infant
  • Lipoxygenase Inhibitors / administration & dosage
  • Lipoxygenase Inhibitors / adverse effects
  • Lipoxygenase Inhibitors / pharmacology*
  • Male
  • Outcome Assessment, Health Care*
  • Sjogren-Larsson Syndrome / drug therapy*

Substances

  • Lipoxygenase Inhibitors
  • zileuton
  • Hydroxyurea